Aridis Pharmaceuticals Inc (ARDS)

$0.00 0.00 (N/A)
Market Cap 11,000.00
Revenue (ttm) 3.09M
Net Income (ttm) -30.37M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -982.85%
Debt to Equity Ratio 0.00
Volume 1,000
Avg Vol 10,622
Day's Range N/A - N/A
Shares Out 53.32M
Stochastic %K 0%
Beta 49.37
Analysts Strong Buy
Price Target $2.00

Company Profile

Aridis Pharmaceuticals, Inc., a late-stage biopharmaceutical company, discovers and develops targeted immunotherapy using fully human monoclonal antibodies (mAb) to treat life-threatening infections. Its lead product candidate is AR-301, a fully human mAb of immunoglobulin 1 (IgG1) that has completed Phase III pivotal trials for the treatment of lung infections resulting from S. aureus alphatoxin, as well as developing AR-301 as an adjunctive therapy with SOC antibiotics to treat hospital acquir...

Industry: Biotechnology
Sector: Healthcare
Phone: 408 385 1742
Fax: 408 356 9548
Address:
983 University Avenue, Building B, Los Gatos, United States
ChiefStockTraderJr
ChiefStockTraderJr May. 12 at 10:01 PM
$ARDS Anything new? Like an old ghost town around here. I can almost hear the squeaking doors moving in the wind. It sure blew away our money like tumbleweeds. Nothing left but a lonely empty shell now. Shoulda been. Coulda been. Woulda been. Hey, let's not kid ourselves, we were robbed like a Jessie James holdup. Make no bones about it.
0 · Reply
CNPPLC
CNPPLC May. 6 at 2:41 PM
$ARDS If the state filing is delinquent., the shareholders can takeover the company under state law and bring the OTC listing to full compliance.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 1 at 1:45 AM
$ARDS My smallest checking account has more money than the entire market cap of this stock. Who works there? Volunteers?
2 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 29 at 5:07 AM
$ARDS I was really disappointed on how this stock played out. I expected it to be some short gold mine or something. A diamond in the rough. It turned out to be just a hard road apple.
1 · Reply
BuyoutBobby
BuyoutBobby Apr. 14 at 7:54 PM
$ARDS they published a news on their website. Maybe its not over yet.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 10 at 10:50 AM
$ARDS I bought this stock years ago and still holding on tho WORTHLESS shares. Has anyone heard any news on it? Anything? Is it completely dead?
1 · Reply
Bigos
Bigos Mar. 16 at 6:35 PM
$ARDS @BuyoutBobby @Shanenobody If Vu had any kind of ethics / belief in the company technology, he would seek a merger with a related, small biotech company, or would look to sell the whole thing on the cheap to someone else. The fact that he hasn't says a whole lot.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Mar. 15 at 1:21 AM
$ARDS
0 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:39 PM
$ARDS So BuyoutBobby exactly when are you going to make sure AstraZeneca's reputation is damaged.
1 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:33 PM
$ARDS
2 · Reply
Latest News on ARDS
No data available.
ChiefStockTraderJr
ChiefStockTraderJr May. 12 at 10:01 PM
$ARDS Anything new? Like an old ghost town around here. I can almost hear the squeaking doors moving in the wind. It sure blew away our money like tumbleweeds. Nothing left but a lonely empty shell now. Shoulda been. Coulda been. Woulda been. Hey, let's not kid ourselves, we were robbed like a Jessie James holdup. Make no bones about it.
0 · Reply
CNPPLC
CNPPLC May. 6 at 2:41 PM
$ARDS If the state filing is delinquent., the shareholders can takeover the company under state law and bring the OTC listing to full compliance.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr May. 1 at 1:45 AM
$ARDS My smallest checking account has more money than the entire market cap of this stock. Who works there? Volunteers?
2 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 29 at 5:07 AM
$ARDS I was really disappointed on how this stock played out. I expected it to be some short gold mine or something. A diamond in the rough. It turned out to be just a hard road apple.
1 · Reply
BuyoutBobby
BuyoutBobby Apr. 14 at 7:54 PM
$ARDS they published a news on their website. Maybe its not over yet.
1 · Reply
ChiefStockTraderJr
ChiefStockTraderJr Apr. 10 at 10:50 AM
$ARDS I bought this stock years ago and still holding on tho WORTHLESS shares. Has anyone heard any news on it? Anything? Is it completely dead?
1 · Reply
Bigos
Bigos Mar. 16 at 6:35 PM
$ARDS @BuyoutBobby @Shanenobody If Vu had any kind of ethics / belief in the company technology, he would seek a merger with a related, small biotech company, or would look to sell the whole thing on the cheap to someone else. The fact that he hasn't says a whole lot.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Mar. 15 at 1:21 AM
$ARDS
0 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:39 PM
$ARDS So BuyoutBobby exactly when are you going to make sure AstraZeneca's reputation is damaged.
1 · Reply
Shanenobody
Shanenobody Feb. 27 at 8:33 PM
$ARDS
2 · Reply
BuyoutBobby
BuyoutBobby Feb. 26 at 7:15 PM
$ARDS Armistice is still holding their shares.
2 · Reply
ReturnOfEsquire
ReturnOfEsquire Feb. 21 at 2:45 AM
$ARDS @Phaaisatroll that buyout/partnership sure is taking a long time, you lying sack of turds.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Feb. 13 at 6:04 PM
$ARDS This was never about making it to market or Vu wouldn't have cut corners on P3 enrollment. This was about the grift and living off retail shareholders.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Jan. 27 at 2:36 AM
$ARDS @Phaaisatroll @Bigos Phaaisa thinking Vu will pop his stupid head in...what a delusional fool.
1 · Reply
Bigos
Bigos Jan. 15 at 7:05 PM
$ARDS Looks like nothing has to happen. They are doing nothing.
1 · Reply
Bigos
Bigos Jan. 13 at 6:38 PM
$ARDS Warum schweigt die Führung von ARDS und benachteiligt die Aktionäre?
0 · Reply
Bigos
Bigos Dec. 30 at 6:57 PM
$ARDS #Germany #Vu #TurnOffTheLights
0 · Reply
ReturnOfEsquire
ReturnOfEsquire Dec. 15 at 5:35 PM
$ARDS
0 · Reply
Bigos
Bigos Nov. 4 at 5:36 PM
$ARDS Looks like Vu probably cashed out, and moved to Germany, to enjoy retirement. He doesn't appear to be doing much with the company over the past year.
1 · Reply
ReturnOfEsquire
ReturnOfEsquire Nov. 3 at 3:29 PM
$ARDS Assuming there was any interest in the company's technology, at this point, they would be negotiating from a point of desperation. Nothing good will happen from here.
0 · Reply
BostonDave
BostonDave Oct. 15 at 11:46 AM
$ARDS sent one last email to their inquiry email address asking for update. Last time Vu responded. Let’s see if there is a response. Otherwise I will harvest the tax loss.
2 · Reply
Bigos
Bigos Oct. 14 at 8:37 PM
$ARDS Yep. Well said. Unfortunately ARDS has a CEO that has failed to provide any actual updates, all while stringing investors along for years. If this company's tech had any value, he would have sold it by now. No pharma appears to be interested in it.
0 · Reply